1 unchanged sentence
Trading Plans
−Removed: On March 13, 2026 , Howard G.
−Removed: Welgus , M.D., a member of our Board of Directors , entered into a Rule 10b5-1 trading plan , intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
−Removed: The plan provided for the potential exercise and sale of up to 49,134 options, as well as the potential sale of 7,609 shares resulting from RSUs vesting between June 15, 2026 and June 15, 2027 .
−Removed: On March 13, 2026 , Todd Franklin Watanabe , our Chief Executive Officer , entered into a Rule 10b5-1 trading plan , intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
+Added: On June 4, 2026 , Todd Franklin Watanabe , our Chief Executive Officer , terminated a Rule 10b5-1 trading plan , which plan was previously adopted on March 13, 2026 and intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
The plan provided for the potential sale of up to 325,000 shares of common stock held by Mr.
Watanabe between June 12, 2026 and June 11, 2027.
−Removed: Table of Content s
+Added: Prior to its termination, no shares were sold under the plan.
+Added: On June 5, 2026 , Todd Franklin Watanabe , our Chief Executive Officer , entered into a Rule 10b5-1 trading plan , intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
+Added: The plan provided for the potential exercise and sale of up to 325,000 options between August 27, 2026 and August 31, 2027 .
+Added: On June 9, 2026 , Masaru Matsuda , our Chief Legal Officer , entered into a Rule 10b5-1 trading plan , intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
+Added: The plan provided for the
+Added: potential exercise and sale of up to 40,000 options, as well as the potential sale of 45,792 shares of common stock held by Mr.
+Added: Matsuda between September 8, 2026 and September 1, 2027 .
Number Description of Document Incorporated by Reference Form Date Number Filed/Furnished Herewith
9 unchanged sentences
Amended and Restated 2022 Employment Inducement Incentive Plan.
−Removed: 31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: 31.2 Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: S-8 4/21/26 99.1
+Added: 10.2# Amended and Restated Non-Employee Director Compensation Program.
+Added: 31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: 31.2 Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C.
15 unchanged sentences
ARCUTIS BIOTHERAPEUTICS, INC.
−Removed: May 06, 2026 By:
+Added: August 05, 2026 By:
/s/ Todd Franklin Watanabe
2 unchanged sentences
(Principal Executive Officer)
−Removed: May 06, 2026 By:
+Added: August 05, 2026 By:
/s/ Latha Vairavan
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.